US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

4.74

-0.2200-4.44%

Post-market: 4.740.00000.00%19:43 EDT

Volume:119.75K

Turnover:586.10K

Market Cap:170.94M

PE:-1.44

High:5.25

Open:4.96

Low:4.70

Close:4.96

Loading ...

Overview Company News Filings

TD Cowen Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)

Anteris Technologies Reports Q1 2025 Results: Net Proceeds of $80M from IPO, $20.8M Allocated to DurAVR® THV Development

BRIEF-Anteris Announces Results For The First Quarter Of 2025

Anteris Technologies Glb Q1 EPS $(0.61) Misses $(0.47) Estimate, Sales $556.00K Beat $466.67K Estimate

Press Release: Anteris Announces Results for the First Quarter of 2025

Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street

Anteris Reports One-Year Patient Outcomes for Duravr® Thv

THOMSON REUTERS

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

BRIEF-Anteris Technologies Global Announces One-Year Patient Outcomes For DurAVR THV - SEC Filing

Anteris Technologies Global - Duravr Thv Shows Favorable Hemodynamic Profile at One-Year - SEC Filing

THOMSON REUTERS

Top Premarket Gainers

MT Newswires Live

Microchip launches AVR SD family of microcontrollers

Lake Street Remains a Buy on Anteris Technologies Global Corp. (AVR)

Reported Earlier, Anteris Technologies 2024 Sales $2.7M And Net Loss after Income Tax $76M

Anteris Technologies Global Corp - Appoints David St Denis as President

THOMSON REUTERS

Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays

Anteris Technologies Initiated at Buy by Lake Street

Anteris Technologies initiated with a Buy at Lake Street

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AVR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR\",,,,,undefined,":{"symbol":"AVR","market":"US","secType":"STK","nameCN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","latestPrice":4.74,"timestamp":1749240000000,"preClose":4.96,"halted":0,"volume":119754,"hourTrading":{"tag":"盘后","latestPrice":4.74,"preClose":4.74,"latestTime":"19:43 EDT","volume":31717,"amount":150306.18,"timestamp":1749253427786},"delay":0,"floatShares":27479955,"shares":36062370,"eps":-3.300801,"marketStatus":"Market Closed","change":-0.22,"latestTime":"06-06 16:00:00 EDT","open":4.96,"high":5.25,"low":4.7,"amount":586098.8651862,"amplitude":0.110887,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.300801,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1734066000000,"exchange":"NASDAQ","adjPreClose":4.96,"preHourTrading":{"tag":"盘前","latestPrice":4.96,"preClose":4.96,"latestTime":"09:29 EDT","volume":670,"amount":3287.1999619999997,"timestamp":1749216599902},"postHourTrading":{"tag":"盘后","latestPrice":4.74,"preClose":4.74,"latestTime":"19:43 EDT","volume":31717,"amount":150306.18,"timestamp":1749253427786},"volumeRatio":0.9433950373913376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR\",,,,,undefined,":{"symbol":"AVR","floatShares":27479955,"roa":"-135.31%","roe":"-263.65%","lyrEps":-3.766913,"volumeRatio":0.9433950373913376,"shares":36062370,"dividePrice":0,"high":5.25,"amplitude":0.110887,"preClose":4.96,"low":4.7,"week52Low":2.34,"pbRate":"3.95","psRate":"68.57","week52High":8.79,"institutionHeld":0,"latestPrice":4.74,"eps":-3.300801,"divideRate":0,"volume":119754,"delay":0,"ttmEps":-3.300801,"open":4.96,"prevYearClose":5.58,"prevWeekClose":4.24,"prevMonthClose":4.24,"prevQuarterClose":3.64,"fiveDayClose":4.24,"twentyDayClose":4.38,"sixtyDayClose":7.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540754343","title":"TD Cowen Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540754343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540754343?lang=en_us&edition=fundamental","pubTime":"2025-06-02 11:35","pubTimestamp":1748835331,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Josh Jennings reiterated a Buy rating on Anteris Technologies Global Corp. (AVR – Research Report) yesterday and set a price targe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-anteris-technologies-global-corp-avr-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-anteris-technologies-global-corp-avr-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVR","TD","COWN"],"gpt_icon":0},{"id":"2535453410","title":"Anteris Technologies Reports Q1 2025 Results: Net Proceeds of $80M from IPO, $20.8M Allocated to DurAVR® THV Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2535453410","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535453410?lang=en_us&edition=fundamental","pubTime":"2025-05-14 18:02","pubTimestamp":1747216948,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. has released its financial results for the quarter ended March 31, 2025. The company reported receiving net proceeds of $80 million from its initial public offering, which commenced on December 12, 2024. These funds have been allocated as follows: $20.8 million was directed towards the ongoing development of DurAVR THV and the preparation and enrollment of the Pivotal Trial for treating severe aortic stenosis, while $10.5 million was used for net working capital and other general corporate purposes, including the repayment of $6.4 million of debt. During the first quarter of 2025, Anteris Technologies incurred payments totaling $1.77 million to related parties and their associates, covering director fees and executive remuneration, which included annual incentive bonuses. These payments were accounted for within cash flows from operating activities. The company emphasizes that there were no payments to related parties or their associates within cash fl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDLc9tD8Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2535359710","title":"BRIEF-Anteris Announces Results For The First Quarter Of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535359710","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535359710?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:11","pubTimestamp":1747174301,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Announces Results For The First Quarter Of 2025May 13 (Reuters) - Anteris Technologies Global Corp AVR.O:ANTERIS ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2025Source text: ID:nGNX9Yhl6JFurther company coverage: AVR.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUABNYXRR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2535903307","title":"Anteris Technologies Glb Q1 EPS $(0.61) Misses $(0.47) Estimate, Sales $556.00K Beat $466.67K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535903307","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535903307?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:58","pubTimestamp":1747173489,"startTime":"0","endTime":"0","summary":"Anteris Technologies Glb Q1 EPS $(0.61) Misses $(0.47) Estimate, Sales $556.00K Beat $466.67K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45394278/anteris-technologies-glb-q1-eps-0-61-misses-0-47-estimate-sales-556-00k-beat-466-67k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR"],"gpt_icon":0},{"id":"2535334060","title":"Press Release: Anteris Announces Results for the First Quarter of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535334060","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535334060?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:45","pubTimestamp":1747172700,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS and BRISBANE, Australia, May 13, 2025  -- Anteris Technologies Global Corp.   a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended March 31, 2025, and provided a corporate update.-- Investigational Device Exemption  for the DurAVR THV's global,pivotal clinical trial , submitted to the FDA. -- Scale up for commencement of the PARADIGM Trial ongoing -- including. expanding the Clinical Specialist Team and contracting with planned. -- Clinical milestone of 100 patients successfully treated with the. DurAVR THV -- comprised of de novo aortic stenosis cases including. The proposed DurAVR THV global pivotal registration trial has been formally designated as the PARADIGM Trial, signifying the trial's central role in the DurAVR THV Clinical Development Program.An IDE application for the PARADIGM Trial was submitted to the U.S. F","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK4022","AVR.AU","BK4082","BK4232","BK7126","AVR","R"],"gpt_icon":0},{"id":"2529293816","title":"Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2529293816","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529293816?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:16","pubTimestamp":1745500565,"startTime":"0","endTime":"0","summary":"In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Anteris Technologies Global Corp. (AVR – Research Report), w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/anteris-technologies-global-corp-avr-receives-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/anteris-technologies-global-corp-avr-receives-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2523910613","title":"Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910613","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910613?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:15","pubTimestamp":1743419700,"startTime":"0","endTime":"0","summary":"MINNEAPOLISand BRISBANE, Australia, March 31, 2025  -- Anteris Technologies Global Corp.   a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices, announces a significant milestone in our mission to restore heart valve patients to healthy function. Our first in class, biomimetic DurAVR Transcatheter Heart Valve  has now been used to treat over 100 patients worldwide, marking a major achievement in our goal to revolutionize cardiac care in patients affected by severe aortic stenosis.Over 100 patients successfully treated with the DurAVR THV, including de novo  aortic stenosis cases, valve-in-valve  patients and complex anatomies such as bicuspid aortic valve patients*. Dr. Michael Reardon, Allison Family Distinguished Chair of Cardiovascular Research and Professor of Cardiothoracic Surgery at the Houston Methodist Hospital and Study Chair of the DurAVR THV Pivotal Trial said, “We are building on a strong foundation of clini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anteris-technologies-reaches-clinical-milestone-111500161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVR","AVR.AU","BK4082"],"gpt_icon":0},{"id":"2521528990","title":"Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2521528990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521528990?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:55","pubTimestamp":1742561741,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen maintained a Buy rating on Anteris Technologies Global Corp. (AVR – Research Report) today and set a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/anteris-technologies-global-corp-avr-receives-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/anteris-technologies-global-corp-avr-receives-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2521407181","title":"Anteris Reports One-Year Patient Outcomes for Duravr® Thv","url":"https://stock-news.laohu8.com/highlight/detail?id=2521407181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521407181?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:30","pubTimestamp":1742556600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUAM3XM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2521400898","title":"Anteris Reports One-Year Patient Outcomes for DurAVR® THV","url":"https://stock-news.laohu8.com/highlight/detail?id=2521400898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521400898?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:30","pubTimestamp":1742556600,"startTime":"0","endTime":"0","summary":"New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-yearMINNEAPOLIS and BRISBANE, Australia, March  21, 2025  (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteri","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/21/3047015/0/en/Anteris-Reports-One-Year-Patient-Outcomes-for-DurAVR-THV.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","IDE","BK4082"],"gpt_icon":0},{"id":"2521405533","title":"BRIEF-Anteris Technologies Global Announces One-Year Patient Outcomes For DurAVR THV - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2521405533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521405533?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:11","pubTimestamp":1742551913,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Technologies Global Announces One-Year Patient Outcomes For DurAVR THV - SEC FilingMarch 21  - Anteris Technologies Global Corp AVR.O:ANTERIS TECHNOLOGIES GLOBAL - ANNOUNCES ONE-YEAR PATIENT OUTCOMES FOR DURAVR THV - SEC FILINGANTERIS TECHNOLOGIES GLOBAL - DURAVR THV SHOWS FAVORABLE HEMODYNAMIC PROFILE AT ONE-YEAR - SEC FILINGSource text: [ID:n0001140361-25-009748]Further company coverage: AVR.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2521403041","title":"Anteris Technologies Global - Duravr Thv Shows Favorable Hemodynamic Profile at One-Year - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403041?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:07","pubTimestamp":1742551638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31DC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2520845848","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520845848","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520845848?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:42","pubTimestamp":1742470946,"startTime":"0","endTime":"0","summary":"OptiNose (OPTN) shares soared 58% pre-bell Thursday after the company said overnight it agreed to a $330 million takeover by Paratek Pharmaceuticals.ProAssurance (PRA) shares surged 49% after the comp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4082","AVR","AVR.AU","BK7007","BK7126","PRA","BK4107","OPTN"],"gpt_icon":0},{"id":"2520026669","title":"Microchip launches AVR SD family of microcontrollers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520026669","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520026669?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:20","pubTimestamp":1742383208,"startTime":"0","endTime":"0","summary":"Microchip (MCHP) Technology has launched the AVR SD family of microcontrollers. The MCUs feature built-in functional safety mechanisms and are desi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/microchip-launches-avr-sd-family-of-microcontrollers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/microchip-launches-avr-sd-family-of-microcontrollers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MCHP","BK4141","BK4213","LU1548497426.USD","LU2087625088.SGD","LU1720051017.SGD","BK4585","BK4529","LU0348723411.USD","LU1720051108.HKD","BK4082","SD","BK4588","LU0353189763.USD","BK4605","BK4604","LU0342679015.USD","BK4512","LU0353189680.USD","LU2357305700.SGD","LU1983260115.SGD","AVR"],"gpt_icon":0},{"id":"2519010488","title":"Lake Street Remains a Buy on Anteris Technologies Global Corp. (AVR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519010488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519010488?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:56","pubTimestamp":1741956978,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen reiterated a Buy rating on Anteris Technologies Global Corp. (AVR – Research Report) today and set a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-remains-a-buy-on-anteris-technologies-global-corp-avr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-remains-a-buy-on-anteris-technologies-global-corp-avr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2519072000","title":"Reported Earlier, Anteris Technologies 2024 Sales $2.7M And Net Loss after Income Tax $76M","url":"https://stock-news.laohu8.com/highlight/detail?id=2519072000","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519072000?lang=en_us&edition=fundamental","pubTime":"2025-03-13 13:58","pubTimestamp":1741845509,"startTime":"0","endTime":"0","summary":"2024 Financial ResultsThe financial results for Anteris for the year ended December 31, 2024 are reviewed below. All amounts in $ refer to U.S. dollars.Net Sales for 2024 were $2.7 millionNet Loss after Income Tax for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44294901/reported-earlier-anteris-technologies-2024-sales-2-7m-and-net-loss-after-income-tax-76m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Reported Earlier, Anteris Technologies 2024 Sales $2.7M And Net Loss after Income Tax $76M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR"],"gpt_icon":0},{"id":"2517185928","title":"Anteris Technologies Global Corp - Appoints David St Denis as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2517185928","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517185928?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:44","pubTimestamp":1741243471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2514288329","title":"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2514288329","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514288329?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025  -- Anteris Technologies Global Corp.   a structural heart company developing DurAVRTHV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference.The details of each conference and how to access them are as follows:. Fireside chat with analyst, Joshua Jennings, and 1x1 meetings. Anteris’ lead product, the DurAVR Transcatheter Heart Valve , was designed in partnership with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood fl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anteris-present-healthcare-investor-conferences-130000956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7126","BK4566","BK4137","BK4585","HCSG","TD","BK4127","AVR","COWN","BK4082","BK4207","BK7007","AVR.AU"],"gpt_icon":0},{"id":"2502705688","title":"Anteris Technologies Initiated at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705688","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502705688?lang=en_us&edition=fundamental","pubTime":"2025-01-09 01:47","pubTimestamp":1736358420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2025 12:47 ET (17:47 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2501724133","title":"Anteris Technologies initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724133?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:16","pubTimestamp":1736342183,"startTime":"0","endTime":"0","summary":"Lake Street initiated coverage of Anteris Technologies (AVR) with a Buy rating and $20 price target Anteris’ DurAVR transcatheter heart valve “prov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anteris-technologies-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anteris-technologies-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AVR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"AVR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1736395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVR","date":"2025-06-06","current":-2.0132,"percent":0.714286,"low":-4.309469,"twenty":-3.427608,"median":-2.694374,"eighty":-1.855525,"high":-1.284919,"avg":-2.643009,"sd":0.783454,"marketCap":164689842.12},"quantilePoints":[{"date":"2024-12-13","current":-4.309469,"twenty":-3.954542,"median":-3.42215,"eighty":-2.889759,"marketCap":241785702.43},{"date":"2024-12-20","current":-2.805718,"twenty":-4.172089,"median":-3.512177,"eighty":-2.811361,"marketCap":201352959.62},{"date":"2024-12-27","current":-2.583453,"twenty":-3.622571,"median":-2.805718,"eighty":-2.757968,"marketCap":185402037.34},{"date":"2025-01-03","current":-2.649507,"twenty":-3.534256,"median":-2.762782,"eighty":-2.579368,"marketCap":190142423.87},{"date":"2025-01-10","current":-2.852132,"twenty":-3.175408,"median":-2.762782,"eighty":-2.600721,"marketCap":204683859.73},{"date":"2025-01-17","current":-3.002665,"twenty":-2.971604,"median":-2.819825,"eighty":-2.634597,"marketCap":215486892.65},{"date":"2025-01-24","current":-2.851831,"twenty":-2.948519,"median":-2.851981,"eighty":-2.666015,"marketCap":204662263.45},{"date":"2025-01-31","current":-2.906655,"twenty":-2.944586,"median":-2.853802,"eighty":-2.693654,"marketCap":208596707.81},{"date":"2025-02-07","current":-3.031153,"twenty":-3.019758,"median":-2.892021,"eighty":-2.72197,"marketCap":217531318.5},{"date":"2025-02-14","current":-4.028787,"twenty":-3.122985,"median":-2.906655,"eighty":-2.759894,"marketCap":289126773.99},{"date":"2025-02-21","current":-4.026548,"twenty":-3.600492,"median":-2.934832,"eighty":-2.768401,"marketCap":288966072.36},{"date":"2025-02-28","current":-3.495725,"twenty":-3.645669,"median":-2.944494,"eighty":-2.793846,"marketCap":250871469.3},{"date":"2025-03-07","current":-3.832499,"twenty":-3.790793,"median":-2.978055,"eighty":-2.807758,"marketCap":275040122.18},{"date":"2025-03-14","current":-3.416065,"twenty":-3.648727,"median":-3.062965,"eighty":-2.819522,"marketCap":260615031.45},{"date":"2025-03-21","current":-2.912731,"twenty":-3.6348,"median":-3.094777,"eighty":-2.837512,"marketCap":222215144.46},{"date":"2025-03-28","current":-2.210641,"twenty":-3.611075,"median":-2.99036,"eighty":-2.768401,"marketCap":168652007.07},{"date":"2025-04-04","current":-1.681137,"twenty":-3.559327,"median":-2.950896,"eighty":-2.657761,"marketCap":128255615.11},{"date":"2025-04-11","current":-1.42483,"twenty":-3.533246,"median":-2.940881,"eighty":-2.567927,"marketCap":108701753.26},{"date":"2025-04-17","current":-1.381221,"twenty":-3.521148,"median":-2.932645,"eighty":-2.443141,"marketCap":105374733.95},{"date":"2025-04-25","current":-2.267775,"twenty":-3.514553,"median":-2.906655,"eighty":-2.267775,"marketCap":173010794.47},{"date":"2025-05-02","current":-2.264443,"twenty":-3.512177,"median":-2.892021,"eighty":-2.267775,"marketCap":172756626.85},{"date":"2025-05-09","current":-2.138136,"twenty":-3.50581,"median":-2.853802,"eighty":-2.138136,"marketCap":163120562.04},{"date":"2025-05-16","current":-1.930992,"twenty":-3.495725,"median":-2.842881,"eighty":-2.048426,"marketCap":157964762.12},{"date":"2025-05-23","current":-1.529866,"twenty":-3.47072,"median":-2.805718,"eighty":-1.914202,"marketCap":125150696.65},{"date":"2025-05-30","current":-1.846631,"twenty":-3.452168,"median":-2.762782,"eighty":-1.892505,"marketCap":151063610.88},{"date":"2025-06-06","current":-2.0132,"twenty":-3.427608,"median":-2.694374,"eighty":-1.855525,"marketCap":164689842.12}],"updateTime":1749318808302}}}